Search results
Drug targeting clear cell renal cell carcinoma shows promising approach
Newswise· 3 days agoApril 23, 2024 – In a groundbreaking phase one clinical trial led by UT Southwestern Medical Center,...
Merck (MRK) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 16 hours agoOutside the U.S., KEYTRUDA growth was driven by continued uptake in earlier-stage cancers, including high-risk, early stage, triple-negative breast...
Merck (MRK) Q1 Earnings Top, Cancer Drug Keytruda Boosts Sales
Zacks via Yahoo Finance· 19 hours agoKeytruda, the biggest product in Merck’s portfolio, generated sales of $6.95 billion in the quarter,...
Moriah Elyse Kerns - Valencia County News-Bulletin
Valencia County News-Bulletin· 23 hours agoMoriah Elyse Kerns, age 27, a resident of Los Lunas, passed away on April 20, 2024, as a result of renal cell carcinoma. Moriah was pursuing ...
Analysts Expect Moderna's First-Quarter Sales To Plummet 95% — Is Moderna Stock A Sell?
Investor's Business Daily· 2 days agoPatients will receive Keytruda or Keytruda plus the vaccine after bladder or kidney removal. Bladder...
Merck highlights progress on HIV, hypertension, cervical cancer drugs
WFMZ Eastern Pennsylvania and Western New Jersey· 18 hours agoMerck got off to an excellent start in the first quarter of 2024. Wall Street met the news with...
Innovent to Present Clinical Data of Multiple Novel Molecules at the 2024 ASCO Annual Meeting
KLAS Las Vegas· 1 day agoFirst-in-class PD-1/IL-2 bispecific antibody fusion protein IBI363 in patients with advanced...
Junshi Biosciences Announces NDA Acceptance in Hong Kong for Toripalimab
Morningstar· 1 day agoShanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization ...
Merck beats earnings forecasts as cancer drug sales boom
Crain's New York Business· 19 hours agoThe guidance comes as Merck’s first-quarter earnings topped $15.8 billion, a 9% increase from the...
How Should You Play Merck (MRK) Stock Ahead of Q1 Earnings?
Zacks via Yahoo Finance· 4 days agoInvestor focus is likely to be on the sales of Merck's (MRK) blockbuster oncology medicine,...